Evidence map›Paper›PMID 41330935›Full record

ArticleNature communications2025

Interplay between T3SS effectors, ExoY activation, and cGMP signaling in Pseudomonas aeruginosa infection.

Vincent Deruelle, Gabrielle Dupuis, Dorothée Raoux-Barbot, Elysa Lim, Roberto Ponce-López, Magda Teixeira Nunes, Daniel Ladant, Louis Renault, Undine Mechold

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Comparative phenotypic and genotypic analysis of distinctFrontiers in cellular and infection microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Vincent DeruelleInstitut Pasteur, Université Paris Cité, CNRS UMR3528, Biochemistry of Macromolecular Interactions Unit, Paris, France. vincent.deruelle@pasteur.fr.ORCID http://orcid.org/0009-0005-4047-1768
Gabrielle DupuisInstitut Pasteur, Université Paris Cité, CNRS UMR3528, Biochemistry of Macromolecular Interactions Unit, Paris, France.
Dorothée Raoux-BarbotInstitut Pasteur, Université Paris Cité, CNRS UMR3528, Biochemistry of Macromolecular Interactions Unit, Paris, France.
Elysa LimInstitut Pasteur, Université Paris Cité, CNRS UMR3528, Biochemistry of Macromolecular Interactions Unit, Paris, France.
Roberto Ponce-LópezInstitut Pasteur, Université Paris Cité, CNRS UMR3528, Biochemistry of Macromolecular Interactions Unit, Paris, France.
Magda Teixeira NunesUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France.ORCID http://orcid.org/0000-0001-9946-6238
Daniel LadantInstitut Pasteur, Université Paris Cité, CNRS UMR3528, Biochemistry of Macromolecular Interactions Unit, Paris, France.ORCID http://orcid.org/0000-0003-1955-548X
Louis RenaultUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France.ORCID http://orcid.org/0000-0003-1722-074X
Undine MecholdInstitut Pasteur, Université Paris Cité, CNRS UMR3528, Biochemistry of Macromolecular Interactions Unit, Paris, France.

Funding

Agence Nationale de la Recherche (French National Research Agency) #ANR-18-CE44-0004Agence Nationale de la Recherche (French National Research Agency) #ANR-23-CE44-0047
6 · The paper itself

Abstract

The Type III Secretion System (T3SS) of Pseudomonas aeruginosa injects effector proteins into host cells to subvert cellular processes and promote infection. While the roles of several T3SS effectors in virulence are well established, the function of the nucleotidyl cyclase ExoY has remained elusive and debated. Here, we show that ExoY-produced cyclic GMP (cGMP) regulates the cytotoxic activity of the co-injected effector ExoT, thereby modulating host cell damage. Using engineered P. aeruginosa strains expressing ExoY variants with distinct substrate preferences, we demonstrate that cGMP production by ExoY limits ExoT-mediated dephosphorylation of the host adaptor protein CrkII, a downstream consequence of ExoT's ADP-ribosyltransferase activity. This attenuation reduces ExoT-induced cell retraction and decreases bacterial virulence. In contrast, we find that ExoT and another T3SS effector, ExoS, can inhibit ExoY activity and cGMP production in certain cell types, thus limiting ExoY's regulatory influence. These findings highlight the intricate interplay between T3SS effectors within host cells and reveal an unrecognized layer of ExoY-based complexity in P. aeruginosa's pathogenic strategy.

Indexed as

Bacterial ProteinsCyclic GMPPseudomonas aeruginosaPseudomonas InfectionsType III Secretion SystemsADP Ribose TransferasesAnimalsBacterial ToxinsGlucosyltransferasesGTPase-Activating ProteinsHost-Pathogen InteractionsHumansPhosphorylationSignal TransductionVirulenceADP Ribose TransferasesBacterial ProteinsBacterial ToxinsCyclic GMPExoT protein, Pseudomonas aeruginosaExoY protein, bacteriaGlucosyltransferasesGTPase-Activating ProteinsType III Secretion Systems

Identifiers

PMID41330935
PMCPMC12770572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.